Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Identifying and targeting angiogenesis-related microRNAs in ovarian cancer.

Chen X, Mangala LS, Mooberry L, Bayraktar E, Dasari SK, Ma S, Ivan C, Court KA, Rodriguez-Aguayo C, Bayraktar R, Raut S, Sabnis N, Kong X, Yang X, Lopez-Berestein G, Lacko AG, Sood AK.

Oncogene. 2019 Jul 9. doi: 10.1038/s41388-019-0862-y. [Epub ahead of print]

PMID:
31289363
2.

Predicting Novel Therapies and Targets: Regulation of Notch3 by the Bromodomain Protein BRD4.

Villar-Prados A, Wu SY, Court KA, Ma S, LaFargue C, Chowdhury MA, Engelhardt MI, Ivan C, Ram PT, Wang Y, Baggerly K, Rodriguez-Aguayo C, Lopez-Berestein G, Ming-Yang S, Maloney DJ, Yoshioka M, Strovel JW, Roszik J, Sood AK.

Mol Cancer Ther. 2019 Feb;18(2):421-436. doi: 10.1158/1535-7163.MCT-18-0365. Epub 2018 Nov 12.

PMID:
30420565
3.

HSP70 Inhibition Synergistically Enhances the Effects of Magnetic Fluid Hyperthermia in Ovarian Cancer.

Court KA, Hatakeyama H, Wu SY, Lingegowda MS, Rodríguez-Aguayo C, López-Berestein G, Ju-Seog L, Rinaldi C, Juan EJ, Sood AK, Torres-Lugo M.

Mol Cancer Ther. 2017 May;16(5):966-976. doi: 10.1158/1535-7163.MCT-16-0519. Epub 2017 Feb 21.

4.

Role of CTGF in Sensitivity to Hyperthermia in Ovarian and Uterine Cancers.

Hatakeyama H, Wu SY, Lyons YA, Pradeep S, Wang W, Huang Q, Court KA, Liu T, Nie S, Rodriguez-Aguayo C, Shen F, Huang Y, Hisamatsu T, Mitamura T, Jennings N, Shim J, Dorniak PL, Mangala LS, Petrillo M, Petyuk VA, Schepmoes AA, Shukla AK, Torres-Lugo M, Lee JS, Rodland KD, Fagotti A, Lopez-Berestein G, Li C, Sood AK.

Cell Rep. 2016 Nov 1;17(6):1621-1631. doi: 10.1016/j.celrep.2016.10.020.

5.

Establishment of lipiodol as a fertility treatment - prospective study of the complete innovative treatment data set.

Court KA, Dare AJ, Weston-Webb M, Hadden WE, Sim RG, Johnson NP.

Aust N Z J Obstet Gynaecol. 2014 Feb;54(1):13-9. doi: 10.1111/ajo.12124. Epub 2013 Sep 13.

PMID:
24033087

Supplemental Content

Loading ...
Support Center